A Multicenter, Open-label, Single-arm, Phase II Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Latest Information Update: 27 Feb 2024
At a glance
- Drugs Mitoxantrone liposomal (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer; Male breast cancer
- Focus Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 22 Feb 2024 Status changed from recruiting to discontinued.
- 21 Jun 2021 New trial record